Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen
Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Malden, MA: Blackwell Science, 2005: 185–6.10.1002/9780470986868Search in Google Scholar
Issitt PD, Anstee PD. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.Search in Google Scholar
Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.10.1016/B978-012586585-2/50007-XSearch in Google Scholar
Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002.10.1002/9780470987018Search in Google Scholar
Mollison PL, Hughes-Jones NC, Lindsay M, Wessely J. Suppression of primary Rh immunization by passively administered antibody. Experiments in volunteers. Vox Sang 1969;16:421–39.10.1111/j.1423-0410.1969.tb04769.xSearch in Google Scholar
Woodrow JC, Clarke CA, Donohow WT, et al. Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression. Br Med J 1975;2:57–9.10.1136/bmj.2.5962.571673020805623Search in Google Scholar
Samson D, Mollison PL. Effect on primary Rh immunization of delayed administration of anti-Rh. Immunology 1975;28: 349–57.Search in Google Scholar
Contreras M, Mollison PL. Failure to augment primary RD immunization using a small dose of “passive” IgG anti-Rh. Br J Haematol 1981;49:371–81.10.1111/j.1365-2141.1981.tb07239.x6794595Search in Google Scholar
Gunson HH, Stratton F, Cooper DG, Rawlinson VI. Primary immunization of Rh-negative volunteers. Br Med J 1970;1: 593–5.10.1136/bmj.1.5696.59316996184985836Search in Google Scholar
Pollack W, Ascari WQ, Crispen JF, O’Connor RR, Ho TY. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion 1971;11: 340–4.10.1111/j.1537-2995.1971.tb04425.x5002766Search in Google Scholar
Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981;21:64–9.10.1046/j.1537-2995.1981.21181127486.x6781108Search in Google Scholar
Gonzalea-Porras JR, Graciani IF, Perez-Simon JA, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D– patients. Transfusion 2008;48:1318–24.10.1111/j.1537-2995.2008.01700.x18422846Search in Google Scholar
Yazer MH, Triulzi DJ. Detection of anti-D in D– recipients transfused with D+ red blood cells. Transfusion 2007;47: 2197–201.10.1111/j.1537-2995.2007.01446.x17714422Search in Google Scholar
Frohn C, Dümbgen L, Brand JM, Görg S, Luhm J, Kirchner H. Probability of anti-D development in D– patients receiving D+ RBCs. Transfusion 2003;43:893–8.10.1046/j.1537-2995.2003.00394.x12823749Search in Google Scholar
Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haematopoietic cell transplants with nonmyeloablative conditioning. Vox Sang 2002;83:358–62.10.1046/j.1423-0410.2002.00235.x12437524Search in Google Scholar
Cid J, Lozano M, Fernández-Avilés F, et al. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion 2006;46:169–73.10.1111/j.1537-2995.2006.00698.x16441590Search in Google Scholar
Ramsey G, Hahn LF, Cornell FW, et al. Low rate of Rhesus immunization from Rh incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989;47:993–5.10.1097/00007890-198906000-0001530051992499963Search in Google Scholar
Casanueva M, Valdes MD, Ribera MC. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994;34:570–2.10.1046/j.1537-2995.1994.34794330009.x8053037Search in Google Scholar
Yuan S, Davis R, Lu Q, Goldfinger D, Ziman AF. Low risk of alloimmunization to the D antigen in D– orthotopic liver transplant recipients receiving D+ RBCs perioperatively (letter). Transfusion 2008;48:2653–5.10.1111/j.1537-2995.2008.01959.x19055536Search in Google Scholar
Boctor FN, Ali NM, Mohandas K, Uehlinger J. Absence of D– alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003;43:173–6.10.1046/j.1537-2995.2003.00289.x12559012Search in Google Scholar
Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients: a study of 30 cases. Vox Sang 1983;45:139–43.10.1111/j.1423-0410.1983.tb01898.x6412457Search in Google Scholar
Cid J, Ortin X, Elies E, Castella D, Panadés M, Martín-Vega C. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002; 42:173–6.10.1046/j.1537-2995.2002.00038.x11896331Search in Google Scholar
Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D– pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002;42:177–82.10.1046/j.1537-2995.2002.00015.x11896332Search in Google Scholar
Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions—risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942–4.10.1056/NEJM1971042928417044994614Search in Google Scholar
Baldwin ML, Ness PM, Scott D, Braine H, Kickler TS. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988;28:330–3.10.1046/j.1537-2995.1988.28488265260.x3133844Search in Google Scholar
Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000;111:980–3.10.1046/j.1365-2141.2000.02414.xSearch in Google Scholar
Cid J, Carbassé G, Pereira A, et al. Platelet transfusions from D+ donors to D– patients: a 10-year follow-up study of 1014 patients. Transfusion 2011;51:1163–9.10.1111/j.1537-2995.2010.02953.x21126258Search in Google Scholar
Asfour M, Narvios A, Lichtiger B. Transfusion of RhD-incompatible blood components in RhD-negative bone marrow transplant recipients. MedGenMed 2004;6:22–7.Search in Google Scholar
Renton PH, Hancock JA. Variability of the rhesus antigen D. Br J Haematol 1956;2:295–304.10.1111/j.1365-2141.1956.tb06701.x13342363Search in Google Scholar
Pollack W, Ascari WQ, Kochesky RJ, O’Connor RR, Ho TY, Tripodi D. Studies on Rh prophylaxis. I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333–9.10.1111/j.1537-2995.1971.tb04424.x5002765Search in Google Scholar
Ting A, Pun A, Dodds AJ, Atkinson K, Biggs JC. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987;27:145–7.10.1046/j.1537-2995.1987.27287150186.x3547785Search in Google Scholar
Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995;35:931–5.10.1046/j.1537-2995.1995.351196110898.x8604491Search in Google Scholar
Dunstan RA, Simpson MB, Rosse WF. Erythrocyte antigens on human platelets. Absence of the Rh, Duffy, Kell, Kidd and Lutheran antigens. Transfusion 1984:24:243–60.10.1046/j.1537-2995.1984.24384225031.x6427991Search in Google Scholar
Menitove JE. Immunoprophylaxis for D– patients receiving platelet transfusions from D+ donors? (editorial). Transfusion 2002;42:136–8.10.1046/j.1537-2995.2002.00074.x11896325Search in Google Scholar
Bolaños-Meade J, Fuch EJ, Luznik L, et al. HLA-haploidentical bone marrow transplantation with posttransfusion cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 2012;120:4285–91.10.1182/blood-2012-07-438408350714022955919Search in Google Scholar
